Susan Hill is the founder of Mestag Therapeutics. Mestag Therapeutics has raised $95M in total funding. Latest round: Seed. Based in Cambridge, UK.
Susan Hill is the founding Chief Executive Officer of Mestag Therapeutics, a biotech company based in Cambridge, UK. The company focuses on developing therapeutics for inflammatory disease and cancer by harnessing fibroblast immunology. Before co-founding Mestag Therapeutics, she held senior leadership positions at several other biopharmaceutical companies.
Full founder directory · Investor directory · Company funding database · Fundraising library